|
1.
|
|
10 p, 1.7 MB |
Cuff-based oscillometric central and brachial blood pressures obtained through ABPM are similarly associated with renal organ damage in arterial hypertension
/
Fernandez-Llama, Patricia (Institut d'Investigació Biomèdica Sant Pau) ;
Pareja, Júlia (Hospital Universitari MútuaTerrassa) ;
Yun, Sergi (Hospital Universitari MútuaTerrassa) ;
Vázquez, Susana (Hospital del Mar (Barcelona, Catalunya)) ;
Oliveras, Anna (Hospital del Mar (Barcelona, Catalunya)) ;
Armario, Pedro (Hospital Moisès Broggi) ;
Blanch, Pedro (Hospital Moisès Broggi) ;
Calero, Francesca (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Sierra, Cristina (Hospital Clínic i Provincial de Barcelona) ;
De La Sierra, Alejandro (Hospital Universitari MútuaTerrassa) ;
Universitat Autònoma de Barcelona
Central blood pressure (BP) has been suggested to be a better estimator of hypertension-associated risks. We aimed to evaluate the association of 24-hour central BP, in comparison with 24-hour peripheral BP, with the presence of renal organ damage in hypertensive patients. [...]
2017 -  10.1159/000485595
Kidney & blood pressure research, Vol. 42 Núm. 6 (2017) , p. 1068-1077
|
|
|
2.
|
|
13 p, 1.4 MB |
Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts : the BiomarCaRE project
/
Rothenbacher, Dietrich (German Cancer Research Center (DKFZ)) ;
Rehm, Martin (Ulm University) ;
Iacoviello, Licia (University of Insubria (Itàlia)) ;
Costanzo, Simona (Istituto Neurologico Mediterraneo Neuromed (Itàlia)) ;
Tunstall-Pedoe, Hugh (University of Dundee) ;
Belch, Jill J.F. (University of Dundee) ;
Söderberg, Stefan (Umeå University) ;
Hultdin, Johan (Umeå University) ;
Salomaa, Veikko (Finnish Institute for Health and Welfare) ;
Jousilahti, Pekka (Finnish Institute for Health and Welfare) ;
Linneberg, Allan (Bispebjerg and Frederiksberg Hospital) ;
Sans, Susana (Institut Català de la Salut (Barcelona)) ;
Padró, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Thorand, Barbara (German Research Center for Environmental Health) ;
Meisinger, C. (Chair of Epidemiology at UNIKA-T Augsburg) ;
Kee, Frank (Queen's University of Belfast) ;
McKnight, Amy Jayne (Queen's University of Belfast) ;
Palosaari, Tarja (Finnish Institute for Health and Welfare) ;
Kuulasmaa, Kari (Finnish Institute for Health and Welfare) ;
Waldeyer, Christoph (University Heart Center Hamburg) ;
Zeller, Tanja (German Center for Cardiovascular Research (DZHK e.V.)) ;
Blankenberg, Stefan (German Center for Cardiovascular Research (DZHK e.V.)) ;
Koenig, Wolfgang (DZHK (German Centre for Cardiovascular Research)) ;
Universitat Autònoma de Barcelona
Chronic kidney disease has emerged as a strong cardiovascular risk factor, and in many current guidelines, it is already considered as a coronary heart disease (CHD) equivalent. Routinely, creatinine has been used as the main marker of renal function, but recently, cystatin C emerged as a more promising marker. [...]
2020 - 10.1186/s12916-020-01776-7
BMC Medicine, Vol. 18 Núm. 1 (december 2020) , p. 300
|
|
|
3.
|
|
11 p, 1.1 MB |
Autosomal dominant polycystic kidney disease in young adults
/
Martínez, Víctor (Hospital Universitario Virgen de la Arrixaca) ;
Furlano, Monica (Institut d'Investigació Biomèdica Sant Pau) ;
Sans, Laia (Hospital del Mar (Barcelona, Catalunya)) ;
Pulido, Lissett (Hospital Universitari Joan XXIII de Tarragona) ;
García, Rebeca (Hospital La Mancha-Centro) ;
Pérez-Gómez, Maria Vanessa (Universidad Autónoma de Madrid) ;
Sánchez-Rodríguez, Jinny (Universidad Autónoma de Madrid) ;
Blasco Pelicano, Miquel (Hospital Clínic i Provincial de Barcelona) ;
Castro-Alonso, Cristina (Hospital Universitario Doctor Peset) ;
Fernández-Fresnedo, Gema (Hospital Universitario Marqués de Valdecilla) ;
Robles, Nicolás Roberto (Hospital Universitario de Badajoz) ;
Valenzuela, María Pau ;
Naranjo, Javier (Hospital Universitario Puerta del Ma) ;
Martín, Nadiam (Hospital Universitari de Girona Doctor Josep Trueta) ;
Pilco, Melissa (Hospital Universitari de Girona Doctor Josep Trueta) ;
Agraz Pamplona, Irene (Hospital Universitari Vall d'Hebron) ;
González-Rodríguez, Juan David (Hospital Universitario Santa Lucía) ;
Panizo, Nayara (Hospital Universitari i Politècnic La Fe (València)) ;
Fraga Rodríguez, Gloria María (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Fernández, Loreto (Hospital Príncipe de Asturias) ;
López, María Teresa (Hospital Universitario Rey Juan Carlos (Madrid)) ;
Dall'Anese, Cecilia (Hospital San Pedro (La Rioja)) ;
Ortiz, Alberto (Universidad Autónoma de Madrid) ;
Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
The clinical manifestations of autosomal dominant polycystic kidney disease (ADPKD) usually appear in adulthood, however pediatric series report a high morbidity. The objective of the study was to analyze the clinical characteristics of ADPKD in young adults. [...]
2022 - 10.1093/ckj/sfac251
Clinical Kidney Journal, Vol. 16 (november 2022) , p. 985-995
|
|
|
4.
|
|
0 p, 533.7 KB |
Longitudinal association of dietary acid load with kidney function decline in an older adult population with metabolic syndrome
/
Valle-Hita, Cristina (Instituto de Salud Carlos III) ;
Becerra-Tomás, Nerea (Imperial College London) ;
Díaz-López, Andrés (Universitat Rovira i Virgili) ;
Vázquez-Ruiz, Zenaida (Universidad de Navarra) ;
Megías, Isabel (Universitat Rovira i Virgili) ;
Corella, Dolores (Universitat de València) ;
Goday Arnó, Albert (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Martínez, J. Alfredo (Institutos Madrileño de Estudios Avanzados) ;
Alonso-Gómez, Ángel María (Osakidetza) ;
Wärnberg, Julia (Universidad de Málaga) ;
Vioque, Jesús (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Romaguera, Dora (Institut d’Investigació Sanitària Illes Balears) ;
López-Miranda, José (Universidad de Córdoba) ;
Estruch, Ramón (Hospital Clínic i Provincial de Barcelona) ;
Tinahones, Francisco J.. (Instituto de Investigación Biomédica de Málaga) ;
Lapetra, José (Distrito Sanitario Atención Primaria Sevilla) ;
Serra-Majem, Luís (Centro Hospitalario Universitario Insular Materno Infantil) ;
Bueno-Cavanillas, Aurora (Universidad de Granada) ;
Tur, Josep A. (Universidad de Balearic Islands) ;
Martín-Sánchez, Vicente (Universidad de León) ;
Pintó, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ;
Gaforio, José J. (Universidad de Jaén) ;
Matía-Martín, Pilar (Universidad Complutense de Madrid) ;
Vidal, Josep (Hospital Clínic i Provincial de Barcelona) ;
Amengual-Galbarte, Angela (Hospital Universitario Rey Juan Carlos (Madrid)) ;
Daimiel, Lidia (Institutos Madrileño de Estudios Avanzados) ;
Ros, Emilio (Hospital Clínic i Provincial de Barcelona) ;
García-Arellano, Ana (Hospital Universitario de Navarra) ;
Barragán, Rocío (Universitat de València) ;
Fitó, Montserrat (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Peña-Orihuela, Patricia J. (Universidad de Córdoba) ;
Asencio-Aznar, Alberto (Centro de Salud Muchamiel) ;
Gómez-Gracia, Enrique (Instituto de Investigación Biomédica de Málaga) ;
Martinez-Urbistondo, Diego (Clínica Universidad de Navarra) ;
Morey, Marga (Institut d’Investigació Sanitària Illes Balears) ;
Casas, Rosa (Hospital Clínic i Provincial de Barcelona) ;
Garrido-Garrido, Eva María (Servicio Andaluz de Salud) ;
Tojal-Sierra, Lucas (Osakidetza) ;
Damas-Fuentes, Miguel (Instituto de Investigación Biomédica de Málaga) ;
Goñi, Estibaliz (Instituto de Investigación Sanitaria de Navarra) ;
Ortega-Azorín, Carolina (Universitat de València) ;
Castañer, Olga (Institut Hospital del Mar d'Investigacions Mèdiques) ;
García-Rios, Antonio (Universidad de Córdoba) ;
Gisbert-Sellés, Cristina (Centre de Salut de Sant Vicent del Raspeig) ;
Sayón-Orea, Carmen (Universidad de Navarra) ;
Schröder, Helmut (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Salas-Salvadó, Jordi (Instituto de Salud Carlos III) ;
Babio, Nancy (Instituto de Salud Carlos III) ;
Universitat Autònoma de Barcelona
Diets high in acid load may contribute to kidney function impairment. This study aimed to investigate the association between dietary acid load and 1-year changes in glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (UACR). [...]
2022 - 10.3389/fnut.2022.986190
Frontiers in nutrition, Vol. 9 (september 2022)
|
|
|
5.
|
|
16 p, 628.4 KB |
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease : A REALI European Pooled Data Analysis
/
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Gourdy, P. (Institute of Metabolic and Cardiovascular Diseases. UMR1048 INSERM/UPS. Toulouse University) ;
Bonadonna, Riccardo C (Department of Medicine and Surgery. University of Parma) ;
Freemantle, N. (Institute of Clinical Trials and Methodology. University College London) ;
Bigot, Gregory (IVIDATA) ;
Mauquoi, C. (IDDI) ;
Ciocca, A. (General Medicines. Sanofi) ;
Bonnemaire, Mireille (General Medicines. Sanofi) ;
Müller-Wieland, D. (Department of Medicine I. University Hospital Aachen)
Introduction: Management of type 2 diabetes mellitus (T2DM) in patients with chronic kidney disease is complex. Using the REALI European pooled database, we determined the impact of baseline renal function on the effectiveness and safety of insulin glargine 300 U/mL (Gla-300) initiated in adults with inadequately controlled T2DM. [...]
2021 - 10.1007/s13300-021-01031-z
Diabetes Therapy, Vol. 12 Núm. 4 (april 2021) , p. 1159-1174
|
|
|
6.
|
|
10 p, 2.0 MB |
Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age
/
Parini, Rossella (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ;
Pintos-Morell, Guillem (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Hennermann, Julia B. (University Medical Center) ;
Hsu, Ting-Rong (Taipei Veterans General Hospital) ;
Karabul, Nesrin (University Children's Hospital and Centre for Rare Diseases) ;
Kalampoki, Vasiliki (Shire (Suïssa)) ;
Gurevich, Andrey (Shire (Suïssa)) ;
Ramaswami, Uma (Royal Free London NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
To determine the impact of initiating enzyme replacement therapy (ERT) with agalsidase alfa early in the course of Fabry disease, we evaluated renal and cardiac outcomes for ≤10 years after ERT initiation in males from the Fabry Outcome Survey (FOS). [...]
2020 - 10.2147/DDDT.S249433
Drug Design, Development and Therapy, Vol. 14 (june 2020) , p. 2149-2158
|
|
|
7.
|
|
9 p, 745.9 KB |
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease
/
Bichet, Daniel G. (Department of Medicine, Hôpital du Sacré-Coeur, University of Montréal, Montreal, Quebec, Canada) ;
Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ;
Wallace, Eric (Department of Medicine, University of Alabama, Birmingham, AL, USA) ;
Hughes, Derralynn A (Lysosomal Storage Disorders Unit, Royal Free London NHS Foundation Trust and University College London, London, UK) ;
Giugliani, Roberto (Instituto Nacional de Genética Médica Populacional (Porto Alegre, Brasil)) ;
Skuban, Nina (Amicus Therapeutics, Inc., Cranbury, NJ, USA) ;
Krusinska, Eva (Amicus Therapeutics, Inc., Cranbury, NJ, USA) ;
Feldt-Rasmussen, Ulla (Copenhagen University Hospital Rigshospitalet) ;
Schiffmann, Raphael (Institute of Metabolic Disease, Baylor Scott & White Research Institute, Dallas, TX, USA) ;
Nicholls, Kathy (Royal Melbourne Hospital (Melbourne, Austràlia)) ;
Universitat Autònoma de Barcelona
The effect of migalastat on long-term renal outcomes in enzyme replacement therapy (ERT)-naive and ERT-experienced patients with Fabry disease is not well defined. An integrated posthoc analysis of the phase 3 clinical trials and open-label extension studies was conducted to evaluate long-term changes in renal function in patients with Fabry disease and amenable GLA variants who were treated with migalastat for ≥2 years during these studies. [...]
2021 - 10.1016/j.ymgmr.2021.100786
Molecular Genetics and Metabolism Reports, Vol. 28 (august 2021)
|
|
|
8.
|
|
5 p, 246.4 KB |
Long-term outcomes with agalsidase alfa enzyme replacement therapy : analysis using deconstructed composite events
/
Beck, Michael (University Medical Center, Mainz, Germany) ;
Hughes, Derralynn A (University College London) ;
Kampmann, Christoph (University Medical Center, Mainz, Germany) ;
Pintos-Morell, Guillem (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ramaswami, Uma (University College London) ;
West, Michael L. (Dalhousie University, Halifax, Canada) ;
Giugliani, Roberto (Universidade Federal do Rio Grande do Sul, Brazil) ;
Universitat Autònoma de Barcelona
This is a retrospective analysis of Fabry Outcome Survey data from children/adults (n = 677) receiving agalsidase alfa enzyme replacement therapy for a median of 3 years, examining cerebrovascular, cardiac, and renal morbidity endpoints separately. [...]
2017 - 10.1016/j.ymgmr.2017.10.008
Molecular Genetics and Metabolism Reports, Vol. 14 (november 2017) , p. 31-35
|
|
|
9.
|
|
7 p, 412.7 KB |
Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease : A Fabry Outcome Survey analysis
/
Beck, Michael (University Medical Center, University of Mainz, Department of Paediatrics) ;
Hughes, Derralynn A (Royal Free London NHS Foundation Trust, University College of London) ;
Kampmann, Christoph (University Medical Center, University of Mainz, Department of Paediatrics) ;
Larroque, Sylvain (Shire, Zug) ;
Mehta, Atul (Royal Free London NHS Foundation Trust, University College of London) ;
Pintos-Morellell, Guillem (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ramaswami, Uma (Royal Free London NHS Foundation Trust, University College of London) ;
West, Michael (Department of Medicine, Dalhousie University) ;
Wijatyk, Anna (Shire) ;
Giugliani, Roberto (Medical Genetics Service HCPA/Dep Genet UFRGS and INAGEMP, Porto Alegre) ;
Universitat Autònoma de Barcelona
Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. [...]
2015 - 10.1016/j.ymgmr.2015.02.002
Molecular Genetics and Metabolism Reports, Vol. 3 (march 2015) , p. 21-27
|
|
|
10.
|
|
8 p, 264.7 KB |
Limited Value of Cystatin-C over Estimated Glomerular Filtration Rate for Heart Failure Risk Stratification
/
Zamora, Elisabet (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
de Antonio Ferrer, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Vila, Joan (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Galán, Amparo (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gastelurrutia, Paloma (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Urrutia de Diego, Agustín (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Background: to compare the prognostic value of estimated glomerular filtration rate, cystatin-C, an alternative renal biomarker, and their combination, in an outpatient population with heart failure. [...]
2012 - 10.1371/journal.pone.0051234
PloS one, Vol. 7 Issue 12 (December 2012) , p. e51234
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
